학술논문
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Document Type
Article
Author
Source
Subject
*SIBUTRAMINE
*WEIGHT loss
*SYMPATHOLYTIC agents
*
*
Language
ISSN
0950-9240
Abstract
Evaluates the efficacy and tolerability of sibutramine for weight loss in obese patients whose hypertension was well-controlled by beta-adrenergic blocking agents with or without concomitant thiazide diuretics. Randomization of patients to sibutramine 20 milligrams once daily or placebo; Mean weight reductions; Mean reductions in serum triglycerides.